Diclofenac Should Be Avoided in Patients with Heart Rate Problems
For patients with tachycardia or other heart rate problems, diclofenac is NOT a suitable choice of NSAID due to its significantly increased cardiovascular risk profile compared to other options. 1
Cardiovascular Risks of Diclofenac
Diclofenac has been consistently associated with higher cardiovascular risks:
- Meta-analyses show diclofenac increases risk of serious cardiovascular events by approximately 40% compared to placebo 1
- Diclofenac has a hazard ratio of 2.40 (95% CI 2.09-2.80) for mortality in patients with prior myocardial infarction 1
- It increases risk of recurrent MI with a hazard ratio of 1.54 (95% CI 1.23-1.93) 1
- Diclofenac has similar cardiovascular risk profile to withdrawn COX-2 inhibitors like rofecoxib 2, 3
Better NSAID Alternatives for Patients with Heart Rate Problems
For patients with tachycardia requiring an NSAID, follow this stepped-care approach:
First-line options (safest cardiovascular profile):
- Acetaminophen (not an NSAID but effective for pain)
- Small doses of narcotics for short-term use
- Nonacetylated salicylates
If first-line ineffective, consider:
Avoid if possible:
- Diclofenac (highest CV risk)
- High-dose ibuprofen (>1200mg/day)
- COX-2 selective inhibitors
Special Considerations for Heart Rate Problems
- Monitor blood pressure within 1-2 weeks of starting any NSAID therapy 4
- NSAIDs can lead to fluid retention and edema, potentially worsening tachycardia 6
- NSAIDs may blunt effects of medications used to treat heart conditions (e.g., diuretics, ACE inhibitors, ARBs) 6
- Low-dose ibuprofen (≤1200mg/day) has a more favorable cardiovascular profile than diclofenac 2
Important Precautions
- If an NSAID must be used in a patient with cardiovascular risk factors, use the lowest effective dose for the shortest duration possible 1, 6
- For patients on aspirin therapy, be aware that ibuprofen may interfere with aspirin's cardioprotective effects 4
- NSAIDs can cause or worsen hypertension, which may exacerbate tachycardia 6
- All NSAIDs carry a black box warning regarding cardiovascular risk, but the magnitude varies significantly between agents 6
Common Pitfalls to Avoid
- Assuming all NSAIDs have equal cardiovascular risk profiles
- Prescribing diclofenac as first-line therapy due to its potent anti-inflammatory effects without considering cardiovascular safety
- Failing to monitor blood pressure and heart rate after initiating NSAID therapy
- Using higher doses than necessary, as cardiovascular risk is dose-dependent
- Continuing NSAID therapy longer than needed, as risk increases with duration of use
In conclusion, when treating patients with tachycardia or other heart rate abnormalities who require anti-inflammatory therapy, naproxen is the safest NSAID option, while diclofenac should be avoided due to its significantly higher cardiovascular risk profile 1, 7.